[{"address1": "11711 North Meridian Street", "address2": "Suite 300", "city": "Carmel", "state": "IN", "zip": "46032", "country": "United States", "phone": "(317) 659-0200", "website": "https://mbxbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter Kent Hawryluk MBA", "age": 55, "title": "CEO, President & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 571200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard B. Bartram CPA", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 578000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven J. Prestrelski M.B.A., MBA, Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Gambino", "title": "Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Graham", "age": 57, "title": "Chief Human Resources Officer", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Salomon  Azoulay M.D.", "age": 66, "title": "Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Dorato DABT, Ph.D.", "title": "Sr. Vice President of Discovery & Non-Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chatan  Charan Ph.D.", "title": "Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Hope", "title": "Senior Vice President of Regulatory & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.41, "open": 7.25, "dayLow": 7.25, "dayHigh": 8.1, "regularMarketPreviousClose": 7.41, "regularMarketOpen": 7.25, "regularMarketDayLow": 7.25, "regularMarketDayHigh": 8.1, "payoutRatio": 0.0, "forwardPE": -3.3304722, "volume": 319940, "regularMarketVolume": 319940, "averageVolume": 272188, "averageVolume10days": 268270, "averageDailyVolume10Day": 268270, "bid": 7.62, "ask": 7.87, "bidSize": 1, "askSize": 1, "marketCap": 259373344, "fiftyTwoWeekLow": 7.25, "fiftyTwoWeekHigh": 27.5, "fiftyDayAverage": 9.894, "twoHundredDayAverage": 16.781704, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -2604881, "profitMargins": 0.0, "floatShares": 13618091, "sharesOutstanding": 33424400, "sharesShort": 4568242, "sharesShortPriorMonth": 3684875, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1367, "heldPercentInsiders": 0.03243, "heldPercentInstitutions": 0.98617995, "shortRatio": 14.0, "impliedSharesOutstanding": 33424400, "bookValue": 7.703, "priceToBook": 1.0073997, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -61922000, "trailingEps": -5.82, "forwardEps": -2.33, "enterpriseToEbitda": 0.038, "52WeekChange": -0.6718816, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 7.76, "targetHighPrice": 44.0, "targetLowPrice": 30.0, "targetMeanPrice": 37.25, "targetMedianPrice": 37.5, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 262148992, "totalCashPerShare": 7.843, "ebitda": -67950000, "totalDebt": 171000, "quickRatio": 23.783, "currentRatio": 24.187, "debtToEquity": 0.066, "returnOnAssets": -0.24168, "returnOnEquity": -0.36713, "freeCashflow": -33270250, "operatingCashflow": -54681000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MBX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1743192309, "regularMarketTime": 1743192002, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.76, "postMarketChange": 0.0, "regularMarketChange": 0.35000038, "regularMarketDayRange": "7.25 - 8.1", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 272188, "fiftyTwoWeekLowChange": 0.5100002, "fiftyTwoWeekLowChangePercent": 0.07034486, "fiftyTwoWeekRange": "7.25 - 27.5", "fiftyTwoWeekHighChange": -19.74, "fiftyTwoWeekHighChangePercent": -0.7178182, "fiftyTwoWeekChangePercent": -67.18816, "earningsTimestamp": 1742212803, "earningsTimestampStart": 1742212803, "earningsTimestampEnd": 1742212803, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -5.82, "epsForward": -2.33, "epsCurrentYear": -2.785, "priceEpsCurrentYear": -2.7863555, "fiftyDayAverageChange": -2.1339998, "fiftyDayAverageChangePercent": -0.21568626, "twoHundredDayAverageChange": -9.021704, "twoHundredDayAverageChangePercent": -0.53759164, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.3 - Strong Buy", "regularMarketChangePercent": 4.7233524, "regularMarketPrice": 7.76, "exchange": "NMS", "messageBoardId": "finmb_613097171", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "MBX Biosciences, Inc.", "longName": "MBX Biosciences, Inc.", "marketState": "CLOSED", "cryptoTradeable": false, "displayName": "MBX Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]